Plandai Biotechnology Inc (PLPL)

[Aston Martin]

"Details" you may find here ( from the blog of PLPL website):


Michael Williams
Posted February 13, 2014

Hallo, I take the liberty to ask threee qestions:

1st
Plandai promised revenues in 2013 which finally unfortunately did not have been generate. When are significant revenues in sight to help confidence in Plandai?

2nd
I am astonished than never any pictures are shown from the inside of the farm building with all machines ready for production. It is nearly 7 months ago that always an empty facility is shown! Why?

3rd
All those deals in the news are great. But when is Plandai able to prove that Phytofare will be more than just a promise and will be accepted by the FDA?

Thank you for your reply.


Plandaí PR
Posted February 13, 2014

Michael,
Thanks for taking the time to ask three very valid questions.
It would be my pleasure to answer them.

1: With the processing and extraction facility coming online shortly we expect therefore to show revenues during 2014. The factory should come online in Q1 with revenues from the sale of extract commencing soon thereafter.

2: Due to the proprietary nature of the technology putting picture of the inside of the factory online could potentially assist our competitors. I will talk to legal and see what pictures are suitable and get it posted to the blog.

3:We expect to have clinical results during Q1 of this year with further trials due to commence during 2014 which will solidify us as the dominant player in our field. With respect to being “accepted by the FDA”, we are not presently pursuing any Phase III human clinical trials for drug targets. No drugs are ever “accepted by the FDA.” A company can receive clearance to market drugs to treat specific conditions but only after Phase III clinical trials are completed and application made to the FDA. We will publish our clinical results as they come available and will commence selling Phytofare as a nutriceutical ingredient as we evaluate their potential for future FDA clearance.

Please feel free to ask as many questions as you like and we truly do appreciate your loyalty as a shareholder.